We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

58 hedge funds and large institutions have $215M invested in Syneron Medical Ltd in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more call options, than puts

Call options by funds: $17K | Put options by funds: $3K

25% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 16

1% less capital invested

Capital invested by funds: $218M → $215M (-$2.45M)

6% less funds holding

Funds holding: 62 → 58 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
58
Holders Change
-4
Holders Change %
-6.45%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
20
Reduced
16
Closed
8
Calls
$17K
Puts
$3K
Net Calls
+$14K
Net Calls Change
-$32K

Top Buyers

Rank Fund Capital Flow
1
NTC
North Tide Capital
Massachusetts
+$5.61M
2
CII
CR Intrinsic Investors
Connecticut
+$2.33M
3
BIP
Brandes Investment Partners
California
+$1.96M
4
Deutsche Bank
Deutsche Bank
Germany
+$852K
5
VAM
Visium Asset Management
New York
+$561K

Top Sellers

Rank Fund Capital Flow
1
PCMI
Paradigm Capital Management Inc
New York
-$3.6M
2
FCM
Frontier Capital Management
Massachusetts
-$1.81M
3
SAM
Steinberg Asset Management
New York
-$1.48M
4
BIM
Bogle Investment Management
Massachusetts
-$876K
5
EIM
Essex Investment Management
Massachusetts
-$674K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$13K – – –
TRCT
52
Tower Research Capital (TRC)
New York
$12K +$7.72K +894 +201%
BIT
53
BlackRock Institutional Trust
California
$6K – – –
LTFS
54
Ladenburg Thalmann Financial Services
Florida
$3K – – –
PIM
55
Profit Investment Management
Maryland
$2.06K -$116K -13,383 -5%
Creative Planning
56
Creative Planning
Kansas
$2K – – –
SFSIG
57
San Francisco Sentry Investment Group
California
$2K – – –
AllianceBernstein
58
AllianceBernstein
Tennessee
$2K +$1.82K +211 New
EIM
59
Essex Investment Management
Massachusetts
– -$674K -77,520 Closed
Goldman Sachs
60
Goldman Sachs
New York
– -$251K -28,818 Closed
BMCMI
61
Bryn Mawr Capital Management Inc
Pennsylvania
– -$230K -26,399 Closed
Morgan Stanley
62
Morgan Stanley
New York
– -$158K -18,115 Closed
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
– -$12K -1,394 Closed
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
– -$4K -515 Closed
Ameriprise
65
Ameriprise
Minnesota
– -$1K -120 Closed
1 2
3

ELOS Hedge Fund Activity: Q3 2013 in Review

58 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2013, worth a combined $215M — down 1.1% from $218M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ELOS and 4 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 20 added.

The largest buyer was North Tide Capital, adding an estimated $5.61M. The largest seller was Paradigm Capital Management Inc, cutting an estimated $3.6M.

  • 58 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2013, down from 62 in Q2 2013.
  • Funds reported $215M of Syneron Medical Ltd stock for Q3 2013, down 1.1% quarter-over-quarter.
  • 4 funds opened new Syneron Medical Ltd positions in Q3 2013 and 8 closed out, a net change of -4 holders.
  • The largest Syneron Medical Ltd buyer in Q3 2013 was North Tide Capital, an estimated $5.61M added.
  • The largest Syneron Medical Ltd seller in Q3 2013 was Paradigm Capital Management Inc, an estimated $3.6M sold.

Based on aggregated 13F filings for Q3 2013.